EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study

Sanchit Mehta, Rajvi Kalpesh Baxi, Parina Manish Rathi, Hetvi Rajesh Pabari, Dhairya Hitesh Shah, Pratik Raghavani, Ajay Rajput

Monaldi Archives for Chest Disease · 06.08.2026

DOI: 10.4081/monaldi.2026.3802 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Monaldi Archives for Chest Disease, online erschienen am 06.08.2026. Verfasst von Sanchit Mehta und 6 weiteren Autor:innen. Beteiligte Einrichtung: BJ Medical College & Civil Hospital, Ahmedabad. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airway obstruction and systemic inflammation, frequently accompanied by metabolic comorbidities, including dyslipidemia. The Atherogenic Index of Plasma (AIP), calculated as log10[triglycerides/high-density lipoprotein (HDL)-cholesterol], is strongly associated with atherosclerotic cardiovascular disease risk, yet its relationship with COPD-associated dyslipidemia remains underexplored. This study investigates the association between atherogenic dyslipidemia profiles and COPD duration, utilizing AIP as an evaluation metric. A hospital-based cross-sectional analytical study was conducted among 100 COPD patients without acute exacerbations. Fasting serum lipid profiles were analyzed using standardized protocols, and AIP was calculated for each participant. Patients were stratified into three AIP risk categories: low risk (AIP0.5). Associations between COPD duration, smoking status, demographic variables, and lipid parameters were examined using chi-square analysis. 60% of COPD patients demonstrated high atherogenic index profiles (AIP>0.5), indicating substantial cardiovascular risk. A significant positive correlation was found between COPD duration and AIP (r=0.456, p

Schlagwörter

Stichwörter der Autor:innen

Atherogenic Index of Plasmacardiovascular riskchronic obstructive pulmonary diseasedyslipidemialipid biomarkers

Autor:innen und Institutionen

  • BJ Medical College & Civil Hospital, Ahmedabad.

Zitieren

APA

Mehta, S., Baxi, R. K., Rathi, P. M., Pabari, H. R., Shah, D. H., Raghavani, P., & Rajput, A. (2026). Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2026.3802

Vancouver

Mehta S, Baxi RK, Rathi PM, Pabari HR, Shah DH, Raghavani P, et al. Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study. Monaldi Archives for Chest Disease. 2026. doi:10.4081/monaldi.2026.3802

BibTeX
@article{Mehta2026,
  author = {Mehta, Sanchit and Baxi, Rajvi Kalpesh and Rathi, Parina Manish and Pabari, Hetvi Rajesh and Shah, Dhairya Hitesh and Raghavani, Pratik and Rajput, Ajay},
  title = {Atherogenic dyslipidemia as a novel cardiovascular risk stratification tool in chronic obstructive pulmonary disease: a hospital-based cross-sectional study},
  journal = {Monaldi Archives for Chest Disease},
  year = {2026},
  doi = {10.4081/monaldi.2026.3802}
}
Kostenlos starten →